Designing a broad-spectrum integrative approach for cancer prevention and treatment.


Targeted therapies and the consequent adoption of "personalized" oncology have achieved notable successes in some cancers; however, significant problems remain with this approach. Many targeted therapies are highly toxic, costs are extremely high, and most patients experience relapse after a few disease-free months. Relapses arise from genetic heterogeneity… (More)
DOI: 10.1016/j.semcancer.2015.09.007


2 Figures and Tables

Blog articles referencing this paper